Anti-CD8 Antibody, Biotin-Labeled

Only %1 left
Catalog #
101779
As low as $335 *

Cat # Size Price*

Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

This purified recombinant antibody is a humanized mouse anti-CD8 a (cluster of differentiation 8 a) antibody. This antibody has a C-terminal Avi-Tag™ on its heavy chain. This antibody recognized human CD8.

Synonyms
Lyt-2, Lyt2, Cd8a, T-cell surface glycoprotein CD8 alpha chain, T-cell surface glycoprotein Lyt-2, CD8a
Product Info
Storage and Usage
Citations
Species
Mouse
Clonality
Monoclonal
Host Species/Expression System
HEK293
Purity

≥90%

Format

Aqueous buffer solution.

Formulation

8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol

MW
Heavy Chain: 51 kDa; Light Chain: 23 kDa + glycans
Glycosylation
This antibody runs at a higher MW by SDS-PAGE due to glycosylation.
UniProt #
P01731
Tag(s)
C-terminal Avi-Tag™
Label

This antibody is enzymatically biotinylated using Avi-Tag™ technology. Biotinylation was confirmed to be ≥90%.

For more information on enzymatic biotinylation, please see our Tech Note

Background

CD8 is a co-receptor for the TCR (T cell receptor) in T cells, binding to MHC (major histocompatibility complex) class I proteins. CD8 is a typical marker of cytotoxic T cells and is involved in signaling. CD8 has two isoforms, a and b. CD8b recruits Lck (lymphocyte-specific protein tyrosine kinase) to the TCR-CD3 complex, and Lck phosphorylates multiple proteins involved in activation of CTLs (cytotoxic T-lymphocytes. It is thus critical for the lysis of cancer cells. Antibodies against CD8 are currently used in the clinic for the diagnostic of cancer, as in the case of crefmirlimab.